p.v has a constant asymptomatic infectivity, in contrast to p.f where infectivity is affected by age and immunity. We must therefore change this when asymptomatic infectivity is assigned (when an individual become asymptomatic). This occurs in initial assignments, when someone becomes infected to an asymptomatic status infection and when a clinical diseased individual recovers to asymptomatic. We can now use the existing update_infection() function for vivax in human_infection and in disease progression.
We now remove the gamma1 parameter from the vivax parameter list, used in the falciparum code.
p.v has a constant asymptomatic infectivity, in contrast to p.f where infectivity is affected by age and immunity. We must therefore change this when asymptomatic infectivity is assigned (when an individual become asymptomatic). This occurs in initial assignments, when someone becomes infected to an asymptomatic status infection and when a clinical diseased individual recovers to asymptomatic. We can now use the existing update_infection() function for vivax in human_infection and in disease progression.
We now remove the gamma1 parameter from the vivax parameter list, used in the falciparum code.